Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Winter

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 20, 2023
B-Mode Ultrasound and Contrast-Enhanced Ultrasound for the Detection of Splenic Involvement in Hodgkin Lymphoma: A Retrospective Analysis of 112 PatientsHajo Findeisen, Christian Görg, Helen Winter, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 29, 2020
Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up TimeIda Netterberg, René Bruno, Ya-Chi Chen, et al.
British Journal of Nursing (Mark Allen Publishing)|April 19, 2025
Decentralising delivery of systemic anti-cancer therapy (SACT) with subcutaneous atezolizumab: service challenges, opportunities and case studiesElaine Tomlins, Helen Winter, Anna Olsson-Brown, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2023
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumorsChaitali Passey, Jenna Voellinger, Leonid Gibiansky, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2019
Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and MethotrexateNicholas Steven Jones, Helen Winter, Tamiko R Katsumoto, et al.
Canine Medicine and Genetics|March 22, 2021
Dog breeds and body conformations with predisposition to osteosarcoma in the UK: a case-control studyGrace L Edmunds, Matthew J Smalley, Sam Beck, et al.
Clinical Pharmacokinetics|November 19, 2024
Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal ImpairmentHaeyoung Zhang, Rita Humeniuk, Sean Regan, et al.
Cancers|August 15, 2019
Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of MicrospheresHelen Winter, Joseph Rassam, Pradeep S Virdee, et al.
Molecular Pharmaceutics|March 10, 2018
In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic CompoundDawen Kou, Chen Zhang, Hiuwing Yiu, et al.
Journal for Immunotherapy of Cancer|November 23, 2019
Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancerColby S Shemesh, Pascal Chanu, Kris Jamsen, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 20, 2023
B-Mode Ultrasound and Contrast-Enhanced Ultrasound for the Detection of Splenic Involvement in Hodgkin Lymphoma: A Retrospective Analysis of 112 PatientsHajo Findeisen, Christian Görg, Helen Winter, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 29, 2020
Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up TimeIda Netterberg, René Bruno, Ya-Chi Chen, et al.
British Journal of Nursing (Mark Allen Publishing)|April 19, 2025
Decentralising delivery of systemic anti-cancer therapy (SACT) with subcutaneous atezolizumab: service challenges, opportunities and case studiesElaine Tomlins, Helen Winter, Anna Olsson-Brown, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2023
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumorsChaitali Passey, Jenna Voellinger, Leonid Gibiansky, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2019
Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and MethotrexateNicholas Steven Jones, Helen Winter, Tamiko R Katsumoto, et al.
Canine Medicine and Genetics|March 22, 2021
Dog breeds and body conformations with predisposition to osteosarcoma in the UK: a case-control studyGrace L Edmunds, Matthew J Smalley, Sam Beck, et al.
Clinical Pharmacokinetics|November 19, 2024
Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal ImpairmentHaeyoung Zhang, Rita Humeniuk, Sean Regan, et al.
Cancers|August 15, 2019
Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of MicrospheresHelen Winter, Joseph Rassam, Pradeep S Virdee, et al.
Molecular Pharmaceutics|March 10, 2018
In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic CompoundDawen Kou, Chen Zhang, Hiuwing Yiu, et al.
Journal for Immunotherapy of Cancer|November 23, 2019
Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancerColby S Shemesh, Pascal Chanu, Kris Jamsen, et al.
Pageof 5